Shanghai Opm Biosciences

Antibody culture media and vaccine culture products developer

placePudong, Shanghai, China calendar_todayFounded 2013 groups261 employees language opmbiosciences.com

Innovation

122 patent families (85 granted) — focus: Chemistry & metallurgy, Physics & computing, Emerging technologies, Human necessities; filing pace steady. Cited 254 times.

YearFilings
20169
20187
20196
202026
202122
20228
202313
202422
202510
20264

Investor mix

7 investors on record; lead investors include CPE, China Life Great Health Fund.

Investor typeCountShare
Venture capital343%
Private equity457%
Coming soon